Answers are grounded in this paper and cite their sources.
The scaling of administered doses to achieve equal degrees of toxic effect in different species has been relatively poorly examined for noncancer toxicity, either empirically or theoretically. We investigate empirical patterns in the correspondence of single oral dose LD, values across several mammalian species for a large number of chemicals based on data reported in the RTECSQ database maintained by the National Institute for Occupational Safety and Health. We find a good correspondence of LD, values across species when the dose levels are expressed in terms of mgadministered per kg of body mass. Our findings contrast with earlier analyses that support scaling doses by the 3/4‐power of body mass to achieve equal subacute toxicity of antineoplastic agents. We suggest that, especially for severe toxicity, single‐ and repeated‐dosing regimes may have different cross‐species scaling properties, as they may depend on standing levels of defenses and rate of regeneration of defenses, respectively.
No takes yet. Share an insight, caveat, or question.
Rhomberg et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: